Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 9:02 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 97 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Memory Losses Clear all

Conditions: Memory Loss, Alzheimer's Disease, Dementia
Interventions: Early Stage Memory Loss Support Group, Educational Seminar; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: Not listed
Enrollment: 154 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Vascular Dementia
Interventions: Rivastigmine; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 50 Years to 85 Years
Enrollment: 708 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2005
U.S. locations: 17
States / cities: Irvine, California • San Francisco, California • Boynton Beach, Florida + 14 more

Conditions: Alzheimer Disease, Hearing Loss, Cognitive Impairment
Interventions: Hearing Intervention, Health Education Intervention; Device · Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 55 Years to 75 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Cognitive Impairment, Dementia, Memory Loss
Interventions: Home Alone; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 55 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Memory Loss (Excluding Dementia), Healthy Lifestyle, Risk Reduction Behavior
Interventions: My Healthy Brain 1, My Healthy Brain 2; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 60 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cognition Disorders
Interventions: Placebo, Solanezumab; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 65 Years to 85 Years
Enrollment: 1,169 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2023
U.S. locations: 62
States / cities: Birmingham, Alabama • Phoenix, Arizona • Sun City, Arizona + 47 more

Conditions: Alzheimer Disease, Memory Disorders, Dementia
Interventions: Participation in a monitored exercise program, Personalized aerobic and strength training.; Behavioral
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 65 Years to 89 Years
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Mild Cognitive Impairment, Alzheimer Disease
Interventions: lyophilized blueberry supplement; Dietary Supplement
Lead sponsor: Duke University; Other
Eligibility: 55 Years to 85 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Memory Loss, Alzheimer Disease, Dementia
Interventions: PorchLight; Other
Lead sponsor: University of Minnesota; Other
Eligibility: Not listed
Enrollment: 342 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Dementia
Interventions: 3D-RT, RT-Verbal; Behavioral
Lead sponsor: Moai Technologies LLC; Other
Eligibility: Not listed
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: St Louis, Missouri • Arlington, Texas

Conditions: Alzheimer's Disease (Incl Subtypes), Dementia, Mild Cognitive Impairment
Interventions: Dance Group, Non-Group Dance, Social Group, No Contact; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 60 Years to 85 Years
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Dementia, Memory Loss, Alzheimer Disease, Executive Dysfunction, Mobility Limitation
Interventions: Transcranial alternating current stimulation (tACS) (active); Transcranial direct current stimulation (tDCS) (active), Transcranial alternating current stimulation (tACS) (sham); Transcranial direct current stimulation (tDCS) (sham), Transcranial alternating current stimulation (tACS) (active); Transcranial direct current stimulation (tDCS) (sham), Transcranial alternating current stimulation (tACS) (sham); Transcranial direct current stimulation (tDCS) (active); Device
Lead sponsor: Hebrew SeniorLife; Other
Eligibility: 55 Years and older
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Alzheimer's Disease
Interventions: Neramexane; Drug
Lead sponsor: Forest Laboratories; Industry
Eligibility: 50 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 34
States / cities: Peoria, Arizona • Phoenix, Arizona • Fresno, California + 30 more

Conditions: Mild Cognitive Impairment, Memory Loss
Interventions: Transcranial magnetic stimulation; Device
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Caregiver Burden, Behavioral and Psychiatric Symptoms of Dementia, Depressive Symptoms, Quality of Life, Psychological Flexibility, Sleep Quality, Positive Aspects of Caregiving
Interventions: Acceptance and Commitment Therapy; Behavioral
Lead sponsor: Utah State University; Other
Eligibility: 18 Years and older
Enrollment: 121 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Logan, Utah

Conditions: Dementia, Early Onset, Alzheimer Dementia (AD), Mild Cognitive Impairment (MCI), Memory Loss
Interventions: Blood draw, Neurocognitive testing, Medical questionnaire; Genetic · Other
Lead sponsor: Columbia University; Other
Eligibility: 35 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Mild Cognitive Impairment, Mild Neurocognitive Disorder, Cognitive Decline, Mental Deterioration, Cognitive Dysfunction, Memory Decline, Memory Loss, Memory Impairment
Interventions: Active rTMS (Bilateral DLPFC), Active rTMS (Bilateral LPC), Placebo rTMS (Inactive); Device
Lead sponsor: Palo Alto Veterans Institute for Research; Other
Eligibility: 55 Years to 90 Years
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Alzheimer's Disease
Interventions: etanercept given by perispinal administration; Drug
Lead sponsor: Tobinick, Edward Lewis, M.D.; Other
Eligibility: 0 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Epilepsy, Seizures, Cognitive Impairment, Mild, Memory Disorder, Memory Loss
Interventions: COBENFY KarXT (50/20 mg), Control; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Alzheimer Disease, Alzheimer Disease, Early Onset, Mild Cognitive Impairment, Memory Loss, Memory Disorders, Memory Impairment
Interventions: Biomarker Data Collection; Other
Lead sponsor: GAP Innovations, PBC; Industry
Eligibility: 60 Years to 85 Years
Enrollment: 1,002 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 16
States / cities: Aventura, Florida • Coral Gables, Florida • Lady Lake, Florida + 13 more

Conditions: Mild Cognitive Impairment (MCI), Mild Neurocognitive Disorder, Neurocognitive Disorders, Cognitive Dysfunction, Cognition Disorders
Interventions: Accelerated iTBS, Computerized Cognitive Training, Sham Computerized Cognitive Training; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 60 Years to 85 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Mild Cognitive Impairment
Interventions: Ketogenic diet, Healthy high carbohydrate diet; Other
Lead sponsor: University of Cincinnati; Other
Eligibility: 50 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2017
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Memory Loss, Memory Deficits, Dementia, Alzheimer Disease
Interventions: Memtrax Memory screening test; Behavioral
Lead sponsor: John Wesson Ashford Jr; Federal
Eligibility: 21 Years and older
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2023
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Alzheimer's Disease
Interventions: etanercept given by perispinal administration; Drug
Lead sponsor: Tobinick, Edward Lewis, M.D.; Other
Eligibility: 0 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Los Angeles, California

Search by objective public record fields.

Efficacy of Early Stage Alzheimer's Support Groups

Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia

Early Age-Related Hearing Loss Investigation (EARHLI)

Home Alone: An Intervention for People With Cognitive Impairment Who Live Alone

Brain Health Program for Older Adults With Subjective Cognitive Decline

Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss

Exercise Treatment of Mild-Stage Probable Alzheimer's Disease

Effect of Blueberry Supplementation on Alzheimer's Biomarkers

The PorchLight Project

Creating Physical Objects With 3D Printers to Stimulate Reminiscing for Memory Loss [2 R44 AG049548-02A1]

Improvisational Movement for People With Memory Loss and Their Caregivers

Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia

The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease

Targeted Transcranial Magnetic Stimulation to Improve Hippocampal-dependent Declarative Memory Abilities

Acceptance Commitment Therapy for Caregivers of People with Memory Loss

Genetic Studies of Early-onset Dementia

Noninvasive Brain Stimulation for Mild Cognitive Impairment

TNF-Alpha Inhibition for Treatment of Alzheimer's Disease

Cholinergic Enhancement of Theta

A Biomarker Database to Investigate Blood-Based and Digital Biomarkers in Participants Screened for Alzheimer's Disease (Bio-Hermes)

Brain Stimulation and Cognitive Training for MCI

Energy Metabolism and Cognitive Aging

Screening for Memory Studies

TNF-Alpha Inhibition for Treatment of Alzheimer's Disease